The astrophysicist is using preimplantation genetic testing (PGT) to eliminate her future children’s risk of inheriting the ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing salpingo ...

"The benefits of RRM and RRSO have been shown for BRCA-mutation carriers without a prior history of cancer, but their impact for BRCA-mutation carriers with a history of early-onset breast cancer ...

Mathew Knowles, father of Beyoncé and Solange, shares his journey as both a music legend and a breast cancer survivor.

"This global study provides the first evidence that risk-reducing surgeries improve survival outcomes among young BRCA-mutation carriers with a prior history of early-onset breast cancer," said ...

"During Breast Cancer Awareness Month, it's especially important to highlight how, by streamlining the diagnostic process for determining BRCA mutation status, we can expand access to BRCA testing ...

About 5% to 10% of female breast cancer patients have a BRCA mutation, according to the American Cancer Society. When breast cancer is diagnosed early, the five-year relative survival rate is over ...

Rucaparib camsylate is under clinical development by pharmaand and currently in Phase II for Endometrial Cancer.

The OlympiA trial supports Lynparza as a standard of care, emphasizing the importance of germline BRCA testing for treatment planning. Adjuvant Lynparza remains beneficial for patients with BRCA1/2 ...

“The benefits of RRM and RRSO have been shown for BRCA-mutation carriers without a prior history of cancer, but their impact for BRCA-mutation carriers with a history of early-onset breast ...